- Exp.Cell Res. 312(5):549-560 (2006)
- PLoS.Pathog. 2(9):e92 (2006)
- J.Thromb.Haemost. 4(11):2461-2469 (2006)
- The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathwayCurr.Clin.Pharmacol. 3(2):132-143 (2008)
- World J.Gastroenterol. 14(17):2691-2701 (2008)
- Annu.Rev.Pathol. (2008)
- Science 282(5390):946-949 (1998)
- J.Leukoc.Biol. 64(2):135-146 (1998)
- Proc.Natl.Acad.Sci.U.S.A 69(6):1408-1412 (1972)
- Clin.Cancer Res. 11(15):5558-5565 (2005)
- Physiol Rev. 82(3):673-700 (2002)
- Genes Dev. 16(7):773-783 (2002)
- Cancer Res. 61(5):1786-1790 (2001)


user